Expanding the applications of immune checkpoint inhibitors in advanced lung cancer beyond disease progression

BACKGROUND: Immunotherapy, particularly the utilization of immune checkpoint inhibitors (ICIs), assumes a pivotal role in the comprehensive management of advanced lung cancer. There has been substantial deliberation regarding the appropriateness of extending ICIs treatment beyond the point of diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chao, Xiong, Xi, Cheng, Ying, Gen, Haiyun, Zhu, Wenqiang, Zhang, Fei, Zhu, Chuandong, Han, Siqi, Liu, Xiufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540839/
https://www.ncbi.nlm.nih.gov/pubmed/37781406
http://dx.doi.org/10.3389/fimmu.2023.1266992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540839/
https://www.ncbi.nlm.nih.gov/pubmed/37781406
http://dx.doi.org/10.3389/fimmu.2023.1266992

Ejemplares similares